Results 21 to 30 of about 64,353 (271)

Pediatric patient with peritoneal mesothelioma harboring ALK rearrangement

Current Problems in Cancer: Case Reports, 2021
Malignant mesothelioma is a rare disease that typically occurs in older patients with prolonged exposure to asbestos. The majority of mesothelioma occurs in the pleura.
Reema A Patel, MD, Miranda Lin, BS, Megan M Harper, MS, MD, Sandra J Beck, MD, Charles S Dietrich, MD, Jill M Kolesar, PhD, MS, Susanne M Arnold, MD, John Hahn, MD, Prakash K Pandalai, MD, Shadi A Qasem, MD, Joseph Kim, MD   +10 more
doaj   +1 more source

Certified causes of death in patients with mesothelioma in South East England

BMC Cancer, 2009
Background Mesothelioma is a highly fatal cancer that is caused by exposure to asbestos fibres. In many populations, the occurrence of mesothelioma is monitored with the use of mortality data from death certification. We examine certified causes of death
Peto Julian, Nicholson Andrew G, Treasure Tom, Okello Catherine, Møller Henrik   +4 more
doaj   +1 more source

Malignant mesothelioma

Pakistan Journal of Medical Sciences, 2013
Malignant Mesothelioma (MM) is a rare but rapidly fatal and aggressive tumor of the pleura and peritoneum with limited knowledge of its natural history. The incidence has increased in the past two decades but still it is a rare tumor. Etiology of all forms of mesothelioma is strongly associated with industrial pollutants, of which asbestos is the ...
Ishtiaq, Ahmed, Salman, Ahmed Tipu, Sundas, Ishtiaq   +2 more
openaire   +2 more sources

Living with mesothelioma: a systematic review of mental health and well-being impacts and interventions for patients and their informal carers

BMJ Open
Objectives Mesothelioma is an aggressive cancer predominantly affecting the lung and abdominal linings. It can have a unique impact on mental health and well-being (MHWB) due to its incurability, poor prognosis and asbestos-exposure causation.
Clare Gardiner, Bethany Taylor, Angela Mary Tod, Stephanie Ejegi-Memeh, Virginia Sherborne, Sarah Hargreaves   +5 more
doaj   +1 more source

Changing Pattern in Malignant Mesothelioma Survival

Translational Oncology, 2015
Survival for mesothelioma has been shown to be poor, with marginal improvement over time. Recent advances in the understanding of pathophysiology and treatment of mesothelioma may impact therapy to improve survival that may not be evident from available ...
Jennifer Faig, Suzanne Howard, Edward A. Levine, Gary Casselman, Mary Hesdorffer, Jill A. Ohar   +5 more
doaj   +1 more source

BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state. [PDF]

PLoS ONE, 2018
Malignant pleural mesothelioma is an aggressive cancer with poor prognosis. Here we have investigated in vitro efficacy of BAMLET and BLAGLET complexes (anti-cancer complexes consisting of oleic acid and bovine α-lactalbumin or β-lactoglobulin ...
Emma M Rath, Yuen Yee Cheng, Mark Pinese, Kadir H Sarun, Amanda L Hudson, Christopher Weir, Yiwei D Wang, Anders P Håkansson, Viive M Howell, Guo Jun Liu, Glen Reid, Robert B Knott, Anthony P Duff, W Bret Church   +13 more
doaj   +1 more source

Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature

Gastroenterology Research and Practice, 2016
Malignant peritoneal mesothelioma with invasion of the liver is an invariably fatal disease. We aimed to clarify the characteristics of malignant peritoneal mesothelioma cases with liver involvement. The clinical presentation, computed tomography images,
Shan-shan Su, Guo-qi Zheng, Ya-gang Liu, Yue-feng Chen, Zhao-wei Song, Shu-jing Yu, Ning-ning Sun, Yu-xin Yang   +7 more
doaj   +1 more source

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making

Insights into Imaging, 2021
The peritoneal cavity is the second commonest site of mesothelioma after the pleural cavity. There are five histological types of peritoneal mesothelioma with variable symptomatology, clinical presentation and prognosis.
Anuradha Chandramohan, Nehal Shah, Andrew Thrower, Norman John Carr, Rohin Mittal, Faheez Mohamed, Brendan Moran   +6 more
doaj   +1 more source

The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma

Oncology Reviews, 2011
Ribonucleases are a superfamily of RNA-cleaving enzymes that can be cytotoxic since the cleavage of RNA makes its information indecipherable. Ranpirnase is a novel ribonuclease which preferentially degrades tRNA, thus leading to an inhibition of protein ...
Luciano Mutti, Giovanni Gaudino
doaj   +2 more sources

Primary pericardial mesothelioma presenting as constrictive pericarditis [PDF]

Archive of Oncology, 2005
Primary pericardial mesothelioma is an extremely rare and lethal cardiac tumor. We report an autopsy case of a primary pericardial mesothelioma in a 52-year-old man.
Karadžić Radovan, Kostić-Banović Lidija, Antović Aleksandra, Čelar Marko, Katić Vuka V., Ilić Goran, Stojanović Jovan   +6 more
doaj   +1 more source